États-Unis · Bourse & Finance · Yahoo Finance

Where Will CRISPR Therapeutics Stock Be in 2030?

Publié par Yahoo Finance · États-Unis il y a 8 h

CRISPR Therapeutics (NASDAQ: CRSP), a gene editing-focused biotech, has made significant clinical and regulatory progress over the past five years. However, over this period, the…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Where Will CRISPR Therapeutics Stock Be in 2030?

À lire aussi

AGNC Investment Q3 2026 Earnings Preview

The next AI race will be won at the credit desk

Hormuz Is Turning Shipping’s Fuel Bill Into a Supply Crisis

No agenda, no rush, no leaving San Francisco: Benchmark’s partners on investing in a frenzied market

Trump Offers Putin Economic Relief in Hopes That Russia Will Return the Favor

Anthropic commits billions to a 'public benefit fund'

Where Will CRISPR Therapeutics Stock Be in 2030?

Partager

À lire aussi

AGNC Investment Q3 2026 Earnings Preview

The next AI race will be won at the credit desk

Hormuz Is Turning Shipping’s Fuel Bill Into a Supply Crisis

No agenda, no rush, no leaving San Francisco: Benchmark’s partners on investing in a frenzied market

Trump Offers Putin Economic Relief in Hopes That Russia Will Return the Favor

Anthropic commits billions to a 'public benefit fund'